Veldoreotide, formerly known as Somatoprim, is a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue which effectively reduces GH secretion in human GH-secreting pituitary adenomas, even in Octreotide non-responsive tumours. References: Paragliola RM, Salvatori R. Novel Somatostatin Receptor Ligands Therapies for Acromegaly. Front Endocrinol (Lausanne). 2018 Mar 7;9:78. doi: 10.3389/fendo.2018.00078. eCollection 2018. Review. PubMed PMID: 29563895; PubMed Central PMCID: PMC5845985.

纯度：≥98%

CAS：252845-37-7